Safety, Tolerability and Pharmacokinetic Characteristics Evaluation of DA-302168S Tablets

Clinical trial NCT06534320 · COMPLETED

Trial details

NCT number: NCT06534320
Sponsor: Chendu DIAO Pharmaceutical Group CO., LTD.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Overweight and Obesity

Start date: 2024-04-18
Primary completion: 2024-12-31
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.